Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kurzhals

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
IEEE Transactions on Visualization and Computer Graphics|September 11, 2015
Evaluation of Fast-Forward Video VisualizationM Hoferlin, K Kurzhals, B Hoferlin, et al.
International Journal of Molecular Sciences|September 23, 2022
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral CenterJonas K Kurzhals, Gina Klee, Victoria Hagelstein, et al.
Melanoma Research|July 20, 2022
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?Gina Klee, Victoria Hagelstein, J K Kurzhals, et al.
Plos One|August 18, 2021
The impact of the Covid-19 pandemic on quality of life in skin cancer patientsJonas K Kurzhals, Gina Klee, Hauke Busch, et al.
Frontiers in Medicine|July 22, 2021
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral CenterJonas K Kurzhals, Tobias Graf, Katharina Boch, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
IEEE Transactions on Visualization and Computer Graphics|September 11, 2015
Evaluation of Fast-Forward Video VisualizationM Hoferlin, K Kurzhals, B Hoferlin, et al.
International Journal of Molecular Sciences|September 23, 2022
Disease Recurrence during Adjuvant Immune Checkpoint Inhibitor Treatment in Metastatic Melanoma: Clinical, Laboratory, and Radiological Characteristics in Patients from a Single Tertiary Referral CenterJonas K Kurzhals, Gina Klee, Victoria Hagelstein, et al.
Melanoma Research|July 20, 2022
Dacarbazine in the management of metastatic melanoma in the era of immune checkpoint therapy: a valid option or obsolete?Gina Klee, Victoria Hagelstein, J K Kurzhals, et al.
Plos One|August 18, 2021
The impact of the Covid-19 pandemic on quality of life in skin cancer patientsJonas K Kurzhals, Gina Klee, Hauke Busch, et al.
Frontiers in Medicine|July 22, 2021
Serum Troponin T Concentrations Are Frequently Elevated in Advanced Skin Cancer Patients Prior to Immune Checkpoint Inhibitor Therapy: Experience From a Single Tertiary Referral CenterJonas K Kurzhals, Tobias Graf, Katharina Boch, et al.
Pageof 1